摘要
目的：探讨血清唾液酸（SA）水平检测在厚发性肝癌（PHc）诊治中的临床价值。方法：回顾性分析2012年01月-2013年12月我院收治的42例原发性肝癌患者血清唾液酸水平检测结果，并与同期56例肝硬化患者及50例健康体检者血清唾液酸水平作对比分析。结果：原发性肝癌患组血清SA水平及阳性率均显著高于正常组及肝硬化患者组，差异有显著性（P〈0．05）。结论：血清SA检测对原发性肝癌的确诊及疗效观察具有重要的临床价值。
Objective： To investigate the serum sialic acid （SA） levels of clinical value in detecting hepatocellular carcinoma （PHc） diagnosis and treatment. Methods： A retrospective analysis of 42 patients with HCC serum siaiic acid level test results in January 2012, December 2013 in our hospital, and compared with 56 cases of liver cirrhosis and 50 heahhy serum siaIic acid levels for comparative analysis. Results： The risk of primary liver cancer and positive serum SA levels were significantly higher than the normal group and the group of patients with cirrhosis, the difference was statistically significant （P 〈0.05）. Conclusion： Serum SA detection has important clinical value and efficacy of diagnosis of primary liver cancer.
出处
《药物与人》
2014年第9期107-108,共2页
Medicine & People
关键词
原发性肝癌
肝硬化
唾液酸
临床价值
Primary liver cancer
Cirrhosis
Sialic acid
CLinical value
